Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulatory Post Marketing Surveillance Study of NovoRapid for New Drug Re-examination

NCT01490112 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01490112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01490112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulatory Post Marketing Surveillance Study of NovoRapid for New Drug Re-examination
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2006
Enrollment
1,239 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1, diabetes mellitus, type 2